Roles of renal proximal tubule transport in the pathogenesis of hypertension

Current Hypertension Reviews

Volumn 9, Issue 2, 2013, Pages 148-155

  Horita, Shoko ^a   Seki, George ^a   Yamada, Hideomi ^a   Suzuki, Masashi ^a   Koike, Kazuhiko ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin II; AT1A; D1; Dopamine; Hypertension; NBCe1; Renal proximal tubule; SHR

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; ANGIOTENSIN II; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BICARBONATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; LEVODOPA; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; SODIUM PROTON EXCHANGE PROTEIN 3;

ARTICLE; BLOOD PRESSURE REGULATION; ENZYME PHOSPHORYLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SODIUM ABSORPTION; WATER PERMEABILITY;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; DOPAMINE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY TUBULES, PROXIMAL; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 84881531411     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/15734021113099990009     Document Type: Article

References (144)

1. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275(20): 1557-62.
2. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115(21): 2761-88.
3. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22(4 Suppl A): 6A-13A.
4. Luft FC, Mervaala E, Müller DN, et al. Hypertension-induced endorgan damage: A new transgenic approach to an old problem. Hypertension 1999; 33(1 Pt 2): 212-8.
5. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38(3 Pt 2): 581-7.
6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351(13): 1296-305.
7. Shibata S, Nagase M, Yoshida S, et al. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 2007; 49(2): 355-64.
8. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch 1977; 367(3): 295-7.
9. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41(3 Pt 2): 625-33.
10. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104(4): 545-56.
11. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15(5): 451-8.
12. Doris PA. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens 2000; 18(5): 509-19.
13. Navar LG, Imig JD, Zou L, et al. Intrarenal production of angiotensin II. Semin Nephrol 1997; 17(5): 412-22.
14. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 2003; 228(2): 134-42.
15. Inagami T, Guo DF, Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens Suppl 1994; 12(10): S83-94.
16. Sasamura H, Hein L, Krieger JE, et al. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 1992; 185(1): 253-9.
17. Burson JM, Aguilera G, Gross KW, et al. Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 1994; 267(2 Pt 1): E260-7.
18. Du Y, Yao A, Guo D, et al. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension 1995; 25(4 Pt 2): 872-7.
19. Gasc JM, Shanmugam S, Sibony M, et al. Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension 1994; 24(5): 531-7.
20. Llorens-Cortes C, Greenberg B, Huang H, et al. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994; 24(5): 538-48.
21. Balmforth AJ, Bryson SE, Aylett AJ, et al. Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells. Br J Pharmacol 1994; 112(1): 277-81.
22. Chen D, Coffman TM. The kidney and hypertension: lessons from mouse models. Can J Cardiol 2012;28(3):305-10.
23. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377(6551): 748-50.
24. Allen AM, Zhuo J, Mendelsohn FA. Localization of angiotensin AT1 and AT2 receptors. J Am Soc Nephrol 1999; 10 Suppl 11: S23-9.
25. Bagby SP, LeBard LS, Luo Z, et al. ANG II AT(1) and AT(2) receptors in developing kidney of normal microswine. Am J Physiol Renal Physiol 2002; 283(4): F755-64.
26. Navar LG, Harrison-Bernard LM, Wang CT, et al. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999; 10 Suppl 11: S189-95.
27. Kobori H, Nishiyama A, Harrison-Bernard LM, et al. Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 2003; 41(1): 42-9.
28. Navar LG, Prieto MC, Satou R, et al. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011;11(2):180-6.
29. Schuster VL, Kokko JP, Jacobson HR. Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 1984; 73(2): 507-15.
30. Harris PJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol 1985; 248(5 Pt 2): F621-30.
31. Liu FY, Cogan MG. Angiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphate. J Clin Invest 1989; 84(1): 83-91.
32. Navar LG, Harrison-Bernard LM, Nishiyama A, et al. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39(2 Pt 2): 316-22.
33. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002; 39(1): 129-34.
34. Seikaly MG, Arant BS, Seney FD. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990; 86(4): 1352-7.
35. Braam B, Mitchell KD, Fox J, et al. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993; 264(5 Pt 2): F891-8.
36. Navar LG, Lewis L, Hymel A, et al. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994; 5(4): 1153-8.
37. Coffman TM, Crowley SD. Kidney in hypertension: guyton redux. Hypertension 2008; 51(4): 811-6.
38. Crowley SD, Gurley SB, Herrera MJ, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006; 103(47): 17985-90.
39. Cervenka L, Vanecková I, Husková Z, et al. Pivotal role of angiotensin II receptor subtype 1A in the development of twokidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens 2008; 26(7):1379-89.
40. Cervenka L, Horácek V, Vanecková I, et al. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 2002; 40(5): 735-41.
41. Han HJ, Park SH, Koh HJ, et al. Mechanism of regulation of Na+ transport by angiotensin II in primary renal cells. Kidney Int 2000; 57(6): 2457-67.
42. Coppola S, Fromter E. An electrophysiological study of angiotensin II regulation of Na-HCO3 cotransport and K conductance in renal proximal tubules. I. Effect of picomolar concentrations. Pflugers Arch 1994; 427(1-2): 143-50.
43. Coppola S, Fromter E. An electrophysiological study of angiotensin II regulation of Na-HCO3 cotransport and K conductance in renal proximal tubules. II. Effect of micromolar concentrations. Pflugers Arch 1994; 427(1-2): 151-6.
44. Houillier P, Chambrey R, Achard JM, et al. Signaling pathways in the biphasic effect of angiotensin II on apical Na/H antiport activity in proximal tubule. Kidney Int 1996; 50(5):1496-505.
45. Aperia A, Holtback U, Syren ML, et al. Activation/deactivation of renal Na+, K(+)-ATPase: a final common pathway for regulation of natriuresis. FASEB J 1994; 8(6): 436-9.
46. Wang T, Chan YL. The role of phosphoinositide turnover in mediating the biphasic effect of angiotensin II on renal tubular transport. J Pharmacol Exp Ther 1991; 256(1): 309-17.
47. Poggioli J, Lazar G, Houillier P, et al. Effects of angiotensin II and nonpeptide receptor antagonists on transduction pathways in rat proximal tubule. Am J Physiol 1992; 263(4 Pt 1): C750-8.
48. Haithcock D, Jiao H, Cui XL, et al. Renal proximal tubular AT2 receptor: signaling and transport. J Am Soc Nephrol 1999; 10(11): S69-74.
49. Sugaya T, Nishimatsu S, Tanimoto K, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 1995; 270(32): 18719-22.
50. Seki G, Coppola S, Fromter E. The Na(+)-HCO3-cotransporter operates with a coupling ratio of 2 HCO3-to 1 Na+ in isolated rabbit renal proximal tubule. Pflugers Arch 1993; 425(5-6): 409-16.
51. Yamada H, Seki G, Taniguchi S, et al. Roles of Ca2+ and PKC in regulation of acid/base transport in isolated proximal tubules. Am J Physiol 1996; 271(5 Pt 2): F1068-76.
52. Geibel J, Giebisch G, Boron WF. Angiotensin II stimulates both Na(+)-H+ exchange and Na+/HCO3-cotransport in the rabbit proximal tubule. Proc Natl Acad Sci U S A 1990; 87(20): 7917-20.
53. Ruiz OS, Qiu YY, Wang LJ, et al. Regulation of the renal Na-HCO3 cotransporter: IV. Mechanisms of the stimulatory effect of angiotensin II. J Am Soc Nephrol 1995; 6(4): 1202-8.
54. Kunimi M, Seki G, Hara C, et al. Dopamine inhibits renal Na+:HCO3-cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 2000; 57(2): 534-43.
55. Horita S, Zheng Y, Hara C, et al. Biphasic regulation of Na+-HCO3-cotransporter by angiotensin II type 1A receptor. Hypertension 2002; 40(5): 707-12.
56. Zheng Y, Horita S, Hara C, et al. Biphasic regulation of renal proximal bicarbonate absorption by luminal AT(1A) receptor. J Am Soc Nephrol 2003; 14(5): 1116-22.
57. Li Y, Yamada H, Kita Y, et al. Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na+-HCO3(-) transport. J Am Soc Nephrol 2008; 19(2): 252-9.
58. Li Y, Yamada H, Kita Y, et al. Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules. Hypertens Res 2008; 31(12): 2155-64.
59. Thomson SC, Deng A, Wead L, et al. An unexpected role for angiotensin II in the link between dietary salt and proximal reabsorption. J Clin Invest 2006; 116(4): 1110-6.
60. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115(4): 1092-9.
61. Gurley SB, Riquier-Brison AD, Schnermann J, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 2011; 13(4): 469-75.
62. Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 2006; 66(5): 2576-83.
63. Li H, Weatherford ET, Davis DR, et al. Renal Proximal Tubule Angiotensin AT1A Receptors Regulate Blood Pressure. Am J Physiol Regul Integr Comp Physiol 2011.
64. Li XC, Zhuo JL. Phosphoproteomic analysis of AT(1) receptormediated signaling responses in proximal tubules of angiotensin IIinduced hypertensive rats. Kidney Int 2011.
65. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 1996; 97(12): 2745-52.
66. Li H, Armando I, Yu P, et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008; 118(6): 2180-9.
67. Andersen PH, Gingrich JA, Bates MD, et al. Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci 1990; 11(6): 231-6.
68. Niznik HB, Van Tol HH. Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatry Neurosci 1992; 17(4): 158-80.
69. Sibley DR, Monsma FJ. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992; 13(2): 61-9.
70. Sokoloff P, Andrieux M, Besançon R, et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol 1992; 225(4): 331-7.
71. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993; 33: 281-307.
72. Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000; 24(1): 125-32.
73. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011; 63(1): 182-217.
74. Dohlman HG, Thorner JW. Regulation of G protein-initiated signal transduction in yeast: paradigms and principles. Annu Rev Biochem 2001; 70: 703-54.
75. Jose PA, Eisner GM, Felder RA. Dopamine receptor-coupling defect in hypertension. Curr Hypertens Rep 2002; 4(3): 237-44.
76. Zeng C, Sanada H, Watanabe H, et al. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19(3): 233-46.
77. Aperia A, Fryckstedt J, Holtbäck U, et al. Cellular mechanisms for bi-directional regulation of tubular sodium reabsorption. Kidney Int 1996; 49(6): 1743-7.
78. Kimura K, White BH, Sidhu A. Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o). J Biol Chem 1995; 270(24): 14672-8.
79. Sidhu A, Kimura K, Uh M, et al. Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J Neurochem 1998; 70(6): 2459-67.
80. Zheng S, Yu P, Zeng C, et al. Galpha12-and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41(3): 604-10.
81. Felder CC, Jose PA, Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther 1989; 248(1): 171-5.
82. Jin LQ, Wang HY, Friedman E. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J Neurochem 2001; 78(5): 981-90.
83. Vyas SJ, Eichberg J, Lokhandwala MF. Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex. J Pharmacol Exp Ther 1992; 260(1): 134-9.
84. Liu J, Wang F, Huang C, et al. Activation of phosphatidylinositollinked novel D1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes. Cell Mol Neurobiol 2009; 29(3): 317-28.
85. Zeng C, Armando I, Luo Y, et al. Dysregulation of dopaminedependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008; 294(2): H551-69.
86. Holmes A, Lachowicz JE, Sibley DR. Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 2004; 47(8): 1117-34.
87. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2(11): 637-50.
88. Lin CY, Varma MG, Joubel A, et al. Conserved motifs in somatostatin, D2-dopamine, and alpha 2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1. J Biol Chem 2003; 278(17): 15128-35.
89. Bacic D, Kaissling B, McLeroy P, et al. Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int 2003; 64(6): 2133-41.
90. Pedrosa R, Gomes P, Hopfer U, et al. Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am J Physiol Renal Physiol 2004; 287(5): F1059-66.
91. Kocinsky HS, Girardi AC, Biemesderfer D, et al. Use of phosphospecific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol 2005; 289(2): F249-58.
92. Albrecht FE, Xu J, Moe OW, et al. Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. Am J Physiol Regul Integr Comp Physiol 2000; 278(4): R1064-73.
93. Chen Z, Leibiger I, Katz AI, et al. Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells. Br J Pharmacol 2009;158(2): 86-93.
94. Cinelli AR, Efendiev R, Pedemonte CH. Trafficking of Na-KATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am J Physiol Renal Physiol 2008; 295(4): F1117-25.
95. Gildea JJ, Israel JA, Johnson AK, et al. Caveolin-1 and dopaminemediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension 2009; 54(5): 1070-6.
96. Khundmiri SJ, Lederer E. PTH and DA regulate Na-K ATPase through divergent pathways. Am J Physiol Renal Physiol 2002; 282(3): F512-22.
97. Efendiev R, Chen Z, Krmar RT, et al. The 14-3-3 protein translates the NA+, K+-ATPase {alpha}1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. J Biol Chem 2005; 280(16):16272-7.
98. Gomes P, Soares-da-Silva P. Dopamine-induced inhibition of Na+-K+-ATPase activity requires integrity of actin cytoskeleton in opossum kidney cells. Acta Physiol Scand 2002; 175(2): 93-101.
99. Lucas-Teixeira VA, Hussain T, Serrão P, et al. Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake. Clin Exp Hypertens 2002;24(5):383-96.
100. Khan F, Spicarová Z, Zelenin S, et al. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 2008; 295(4): F1110-6.
101. Brismar H, Asghar M, Carey RM, et al. Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A 1998; 95(10): 5573-8.
102. Asghar M, Kansra V, Hussain T, et al. Hyperphosphorylation of Na-pump contributes to defective renal dopamine response in old rats. J Am Soc Nephrol 2001; 12(2): 226-32.
103. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na, KATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol 2005; 25(5): 322-7.
104. Yao LP, Li XX, Yu PY, et al. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 1998; 32(6): 1049-53.
105. Satoh T, Ominato M, Katz AI. Different mechanisms of renal Na-K-ATPase regulation by dopamine in the proximal and distal nephron. Hypertens Res 1995; 18(1): S137-40.
106. Bertorello AM, Sznajder JI. The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks. Am J Respir Cell Mol Biol 2005; 33(5): 432-7.
107. Cunningham R, Biswas R, Brazie M, et al. Signaling pathways utilized by PTH and dopamine to inhibit phosphate transport in mouse renal proximal tubule cells. Am J Physiol Renal Physiol 2009; 296(2): F355-61.
108. Baines AD, Drangova R. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells? J Am Soc Nephrol 1998; 9(9): 1604-12.
109. Glahn RP, Onsgard MJ, Tyce GM, et al. Autocrine/paracrine regulation of renal Na(+)-phosphate cotransport by dopamine. Am J Physiol 1993; 264(4 Pt 2): F618-22.
110. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 2003; 285(6): F1233-43.
111. Jin Y, Kuznetsova T, Tikhonoff V, et al. Segmental renal sodium handling in relation to the human SAH gene. Hypertension 2008; 52(2): e12-3.
112. Saito O, Ando Y, Kusano E, et al. Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. Am J Physiol Renal Physiol 2001; 281(1): F114-22.
113. Sun D, Schafer JA. Dopamine inhibits AVP-dependent Na+ transport and water permeability in rat CCD via a D4-like receptor. Am J Physiol 1996;271(2 Pt 2): F391-400.
114. Aoki Y, Albrecht FE, Bergman KR, et al. Stimulation of Na(+)-K(+)-2Cl-cotransport in rat medullary thick ascending limb by dopamine. Am J Physiol 1996; 271(6 Pt 2): R1561-7.
115. Kaneda Y, Bello-Reuss E. Effect of dopamine on phosphate reabsorption in isolated perfused rabbit proximal tubules. Miner Electrolyte Metab 1983; 9(3): 147-50.
116. Bello-Reuss E, Higashi Y, Kaneda Y. Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol 1982; 242(6): F634-40.
117. Baum M, Quigley R. Inhibition of proximal convoluted tubule transport by dopamine. Kidney Int 1998; 54(5): 1593-600.
118. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84(6): 1849-56.
119. Sanada H, Jose PA, Hazen-Martin D, et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33(4): 1036-42.
120. Jose PA, Felder RA. What we can learn from the selective manipulation of dopaminergic receptors about the pathogenesis and treatment of hypertension? Curr Opin Nephrol Hypertens 1996; 5(5): 447-51.
121. Li D, Scott L, Crambert S, et al. Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation. J Am Soc Nephrol 2012; 23(3): 421-8.
122. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002; 99(6): 3872-7.
123. Watanabe H, Xu J, Bengra C, et al. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 2002; 62(3): 790-8.
124. Zeng C, Villar VA, Eisner GM, et al. G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension 2008; 51(6): 1449-55.
125. Premont RT, Macrae AD, Aparicio SA, et al. The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation. J Biol Chem 1999; 274(41): 29381-9.
126. Premont RT, Macrae AD, Stoffel RH, et al. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem 1996; 271(11): 6403-10.
127. Sanada H, Yatabe J, Midorikawa S, et al. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 2006; 47(6): 1131-9.
128. Virlon B, Firsov D, Cheval L, et al. Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants. Endocrinology 1998; 139(6): 2784-95.
129. Sallese M, Mariggiò S, Collodel G, et al. G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells. J Biol Chem 1997; 272(15): 10188-95.
130. Rankin ML, Marinec PS, Cabrera DM, et al. The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol 2006; 69(3): 759-69.
131. Tiberi M, Nash SR, Bertrand L, et al. Differential regulation of dopamine D1A receptor responsiveness by various G proteincoupled receptor kinases. J Biol Chem 1996; 271(7): 3771-8.
132. Villar VA, Jones JE, Armando I, et al. G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem 2009; 284(32): 21425-34.
133. Ménard L, Ferguson SS, Barak LS, et al. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration. Biochemistry 1996; 35(13): 4155-60.
134. Munshi UM, Peegel H, Menon KM. Palmitoylation of the luteinizing hormone/human chorionic gonadotropin receptor regulates receptor interaction with the arrestin-mediated internalization pathway. Eur J Biochem 2001; 268(6): 1631-9.
135. Chen W, Li S, Srinivasan SR, et al. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood: the Bogalusa Heart Study. Hypertension 2005; 45(5): 954-9.
136. Allayee H, de Bruin TW, Michelle Dominguez K, et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38(4): 773-8.
137. Zhu H, Lu Y, Wang X, et al. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens 2006; 19(1): 61-6.
138. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 2007; 49(1): 96-106.
139. Staessen JA, Kuznetsova T, Zhang H, et al. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008; 51(6): 1643-50.
140. Bertorello A, Hökfelt T, Goldstein M, et al. Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol 1988; 254(6 Pt 2): F795-801.
141. Adam WR, Culvenor AJ, Hall J, et al. Aromatic L-amino acid decarboxylase: histochemical localization in rat kidney and lack of effect of dietary potassium or sodium loading on enzyme distribution. Clin Exp Pharmacol Physiol 1986; 13(1): 47-53.
142. Hayashi M, Yamaji Y, Kitajima W, et al. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990; 258(1 Pt 2): F28-33.
143. Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 2011; 121(7): 2845-54.
144. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009; 119(3): 524-30.